Regarding laboratory studies, recent immunohistochemical studies have suggested the use of single antibodies such as ki‐ 67, Ber‐EP4, CD34,CK 20, Bcl2 and AR to differentiate BCC from BFH. Here, EPCAM is linked to skin basal cell carcinoma.